Basic Information

Symbol
circGCN1L1
RNA Class
circRNA
Alias
GCN1 Activator Of EIF2AK4 KIAA0219 GCN1L1 GCN1L GCN1 (General Control Of Amino-Acid Synthesis 1, Yeast)-Like 1 General Control Of Amino-Acid Synthesis 1-Like Protein 1 GCN1, EIF2 Alpha Kinase Activator Homolog GCN1 EIF-2-Alpha Kinase Activator Homolog Stalled Ribosome Sensor GCN1 Translational Activator GCN1 GCN1-Like Protein 1 HsGCN1 Peroxisome Proliferator Activated Receptor Interacting Complex Protein GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 (Yeast) GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 EIF-2-Alpha Kinase Activator GCN1 PRIC295
Location (GRCh37)
12:120567080-120632513 UCSC Genome Browser
Location (GRCh38)
Host gene
GCN1L1
Host category
mRNA
Forensic tag(s)
Other applications
External database

Transcripts

ID Type Location (GRCh37) Location (GRCh38) Length GC content
hsa_GCN1L1_0010200 Exon-Exon chr12:120591017-120598059 chr12:120153213-120160255 1626 nt 0.5935
hsa_GCN1L1_0010300 Exon-Exon chr12:120591017-120602525 chr12:120153213-120164721 2450 nt 0.5845
hsa_GCN1L1_0010400 Exon-Exon chr12:120591017-120615358 chr12:120153213-120177555 250 nt 0.4440
hsa_GCN1L1_0010500 Exon-Exon chr12:120591017-120616562 chr12:120153213-120178759 250 nt 0.4760
hsa_GCN1L1_0010600 Exon-Exon chr12:120591017-120621480 chr12:120153213-120183677 250 nt 0.4800
hsa_GCN1L1_0010700 Exon-Exon chr12:120591071-120591658 chr12:120153267-120153854 252 nt 0.5437
hsa_chr12_0134500 Intergenic-Intergenic chr12:120591147-120591648 chr12:120153343-120153844 502 nt 0.5598
hsa_GCN1L1_0011100 Exon-Exon chr12:120592774-120592844 chr12:120154970-120155040 71 nt 0.5775
hsa_GCN1L1_0011200 Exon-Exon chr12:120592774-120593234 chr12:120154970-120155430 261 nt 0.5862
hsa_GCN1L1_0011300 Exon-Exon chr12:120592774-120593523 chr12:120154970-120155719 389 nt 0.5707
Showing 81 to 90 of 152 entries
Forensic Context

A review consolidating existing research indicates that in various mammalian species, the circGCN1L1 serves as an example where its expression was experimentally abolished using CRISPR/Cas9 genome-editing without affecting the expression of its corresponding linear mRNA [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].